An Icelandic medical device company has developed sprays to prevent coronavirus infection. Already on sale in Iceland, the sprays are set to hit pharmacy shelves overseas in the coming months.
Icelandic medical device company Kerecis, based in Ísafjörður, has adapted a spreay from its subsidiary company Viruxal ltd, already used by hospitals to treat open wounds, for use orally and nasally to prevent COVID-19.
Italian doctors tried the wound spray on coronavirus patients this spring with encouraging results. Kerecis has spent the summer developing preventative throat and nasal sprays that destroy 99.97 percent of the virus.
“The idea is for if you want extra protection," explains Guðmundur Fertram Sigurjónsson, CEO and founder of Kerecis. "If you’re going out to eat, or on a coach or an aeroplane, then you can spray this in the nose or mouth and receive this extra protection.”
The spray is intended to be useful as a pre-emptive protection against COVID-19. Using it does not mean people can stop other personal protections such as hand washing, sanitisation, and face masks.
“It is fatty acids that dissolve the virus, or rather the fatty layer of the virus. Just the same as soap does on our hands, this forms a protective layer in the airways that destroys the virus as you inhale it,” Guðmundur says.